Glimepiride, Metformin SR, and Voglibose"""

Glimepiride, Metformin SR, and Voglibose 
SEIZMET TRIO are medications commonly used in the management of type 2 diabetes mellitus. They work in different ways to help control blood sugar levels and improve insulin sensitivity. Glimepiride: Glimepiride is an oral antidiabetic medication that belongs to the class of drugs known as sulfonylureas. SEIZMET TRIO helps lower blood sugar levels by stimulating the release of insulin from the pancreas and increasing the sensitivity of insulin receptors in the body's tissues. Glimepiride is typically taken once daily before a meal. Metformin SR: Metformin is an oral antidiabetic medication that belongs to the class of drugs called biguanides. SEIZMET TRIO works by reducing the amount of glucose produced by the liver, increasing insulin sensitivity, and improving the uptake of glucose by the muscles. Metformin SR (sustained-release) is a modified-release formulation that provides a controlled release of the medication over an extended period. SEIZMET TRIO is usually taken once or twice daily with meals. Voglibose: Voglibose is an oral antidiabetic medication classified as an alpha-glucosidase inhibitor. SEIZMET TRIO works by slowing down the digestion and absorption of carbohydrates in the intestine. By inhibiting the enzymes responsible for breaking down complex carbohydrates into glucose, voglibose helps to reduce postprandial (after-meal) spikes in blood sugar levels. SEIZMET TRIO is typically taken with meals. SEIZMET TRIO medications are often prescribed in combination or as part of a comprehensive treatment plan for type 2 diabetes. The combination of SEIZMET TRIO helps to address different aspects of blood sugar control, such as stimulating insulin release, improving insulin sensitivity, and reducing postprandial glucose levels. SEIZMET TRIO is available in strengths of 0.2 and 0.3 mg.
For further information please contact: 
info@sterispharma.com 
Order Now - https://www.sterisonline.com/product/seizmet-trio-0-2-133445